blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2739605

EP2739605 - PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF AGOMELATINE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.03.2017
Database last updated on 30.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Laboratorio Chimico Internazionale S.p.A.
Largo Donegani Guido 2
20121 Milano / IT
[2014/24]
Inventor(s)01 / BERTOLINI, Giorgio
c/o LABORATORIO CHIMICO INTERNAZIONALE S.p.A.
Via B. Cellini 20
20090 Segrate (Ml) / IT
02 / DE ANGELIS, Bruno
c/o LABORATORIO CHIMICO INTERNAZIONALE S.p.A.
Via B. Cellini 20
20090 Segrate (Ml) / IT
 [2014/24]
Representative(s)Trupiano, Federica
Marietti, Gislon e Trupiano S.r.l.
Via Larga, 16
20122 Milano / IT
[2016/17]
Former [2014/24]Trupiano, Federica
Marietti, Gislon e Trupiano S.r.l. Via Larga, 16
20122 Milano / IT
Application number, filing date11770507.903.08.2011
[2016/17]
WO2011IB01805
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013017903
Date:07.02.2013
Language:EN
[2013/06]
Type: A1 Application with search report 
No.:EP2739605
Date:11.06.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 07.02.2013 takes the place of the publication of the European patent application.
[2014/24]
Type: B1 Patent specification 
No.:EP2739605
Date:27.04.2016
Language:EN
[2016/17]
Search report(s)International search report - published on:EP07.02.2013
ClassificationIPC:C07C231/00, C07C233/18
[2014/24]
CPC:
C07C233/18 (EP,US); C07C233/25 (US); C07C231/22 (EP,US);
C07B2200/13 (EP,US)
C-Set:
C07C231/22, C07C233/18 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/24]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER KRISTALLINEN FORM I VON AGOMELATIN[2014/24]
English:PROCESS FOR THE PREPARATION OF CRYSTALLINE FORM I OF AGOMELATINE[2014/24]
French:PROCÉDÉ DE PRÉPARATION DE LA FORME CRISTALLINE I DE L'AGOMÉLATINE[2014/24]
Entry into regional phase15.01.2014National basic fee paid 
15.01.2014Designation fee(s) paid 
15.01.2014Examination fee paid 
Examination procedure15.01.2014Examination requested  [2014/24]
19.09.2014Amendment by applicant (claims and/or description)
27.10.2015Communication of intention to grant the patent
19.02.2016Fee for grant paid
19.02.2016Fee for publishing/printing paid
22.02.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.03.2016Information about intention to grant a patent
14.03.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.10.2015
Opposition(s)30.01.2017No opposition filed within time limit [2017/14]
Fees paidRenewal fee
15.01.2014Renewal fee patent year 03
30.07.2014Renewal fee patent year 04
24.07.2015Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL27.04.2016
BG27.04.2016
EE27.04.2016
LT27.04.2016
MK27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
SM27.04.2016
NO27.07.2016
LU03.08.2016
[2018/46]
Former [2018/38]BG27.04.2016
EE27.04.2016
LT27.04.2016
MK27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
SM27.04.2016
NO27.07.2016
LU03.08.2016
Former [2018/31]EE27.04.2016
LT27.04.2016
MK27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
SM27.04.2016
NO27.07.2016
LU03.08.2016
Former [2017/44]EE27.04.2016
LT27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
SM27.04.2016
NO27.07.2016
LU03.08.2016
Former [2017/13]EE27.04.2016
LT27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
SM27.04.2016
NO27.07.2016
Former [2017/10]EE27.04.2016
LT27.04.2016
RO27.04.2016
RS27.04.2016
SE27.04.2016
NO27.07.2016
Former [2016/52]LT27.04.2016
RS27.04.2016
SE27.04.2016
NO27.07.2016
Former [2016/50]LT27.04.2016
RS27.04.2016
NO27.07.2016
Former [2016/46]LT27.04.2016
NO27.07.2016
Cited inInternational search[XD]EP2319827  (RATIOPHARM GMBH [DE]) [XD] 9 * claim 1 *;
 [XD]  - TINANT B ET AL, "N-Ä2-(7-METHOXY-1-NAPHTHYL)ETHYLÜACETAMIDE, A POTENT MELATONIN ANALOG", ACTA CRYSTALLOGRAPHICA SECTION C. CRYSTAL STRUCTURE COMMUNICATIONS, MUNKSGAARD, COPENHAGEN, DK, (19940101), vol. C50, no. 6, doi:10.1107/S0108270193012922, ISSN 0108-2701, pages 907 - 910, XP009047983 [XD] 9 * the whole document *

DOI:   http://dx.doi.org/10.1107/S0108270193012922
 [A]  - Petit S. et al., "The Amorphous State", Petit S. et al., Hilfiker R. et al., Polymorphism in the Pharmaceutical Industry, Weinheim, WILEY-VCH, (2006), pages 263 - 265, ISBN 3-527-31146-7, XP002666940 [A] 1-8 * page 265, paragraph 10.3.3 *
by applicantEP0447285
 EP1564202
 CN101704763
 EP2319827
    - ACTA CRYST., (1994), vol. C50, pages 907 - 910
    - ACTA CRYST, (1994), vol. C50, pages 907 - 910
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.